Flavio Kapczinski

Author PubWeight™ 62.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2007 1.78
2 Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011 1.71
3 Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008 1.46
4 The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Rev Bras Psiquiatr 2011 1.46
5 Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry 2013 1.43
6 Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006 1.34
7 Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 2006 1.17
8 Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 2006 1.16
9 Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry 2013 1.12
10 [Performance of the Self-Reporting Questionnaire as a psychiatric screening questionnaire: a comparative study with Structured Clinical Interview for DSM-IV-TR]. Cad Saude Publica 2008 1.09
11 Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008 1.08
12 Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004 1.04
13 Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav 2011 1.03
14 Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 2011 1.03
15 A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry 2008 1.02
16 Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord 2007 1.01
17 Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett 2007 0.98
18 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 2009 0.97
19 Effects of gabapentin on anxiety induced by simulated public speaking. J Psychopharmacol 2003 0.96
20 DNA damage in bipolar disorder. Psychiatry Res 2007 0.96
21 Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009 0.94
22 Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disord 2008 0.92
23 The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 2011 0.91
24 DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.91
25 Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 2008 0.91
26 Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial. Psychother Psychosom 2003 0.90
27 Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res 2012 0.90
28 The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 2009 0.90
29 Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res 2009 0.90
30 Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev Bras Psiquiatr 2013 0.89
31 The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 2010 0.89
32 Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci 2008 0.88
33 Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res 2012 0.88
34 Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 2006 0.87
35 Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review. Curr Psychiatry Rep 2015 0.87
36 Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neurosci Lett 2011 0.86
37 Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice. Neurosci Lett 2010 0.84
38 Childhood trauma, impulsivity, and executive functioning in crack cocaine users. Compr Psychiatry 2011 0.84
39 Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial. BMC Med 2012 0.83
40 Sleep and circadian rhythm disturbances in bipolar disorder: an urgent need for objective assessment and systematic follow-up. J Clin Psychiatry 2011 0.82
41 Immunoassay for glial fibrillary acidic protein: antigen recognition is affected by its phosphorylation state. J Neurosci Methods 2007 0.82
42 Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy. Rev Bras Psiquiatr 2012 0.82
43 The impact of comorbid posttraumatic stress disorder on bipolar disorder patients. J Affect Disord 2009 0.82
44 Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. J Psychiatr Res 2009 0.81
45 Cognitive impairment in school-aged children with early trauma. Compr Psychiatry 2012 0.81
46 Prevalence and clinical impact of eating disorders in bipolar patients. Rev Bras Psiquiatr 2012 0.80
47 Emotional memory in bipolar disorder. Br J Psychiatry 2008 0.80
48 Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels. Curr Neurovasc Res 2008 0.80
49 Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Res 2004 0.80
50 Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. Int J Neuropsychopharmacol 2013 0.80
51 Is there an association between suicide attempt and delay of initiation of mood stabilizers in bipolar I disorder? J Affect Disord 2011 0.80
52 Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatr Res 2010 0.80
53 Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 2008 0.79
54 An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry 2003 0.79
55 Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males. Neurosci Lett 2008 0.79
56 The identification of unipolar mania subtype based on anxiety comorbidity. J Affect Disord 2011 0.78
57 Improvement of schizophrenia with electroconvulsive therapy and serum brain-derived neurotrophic factor levels: Lack of association in a pilot study. Psychiatry Clin Neurosci 2010 0.78
58 Epidemiology and management of anxiety in patients with bipolar disorder. CNS Drugs 2009 0.78
59 Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder. J Psychiatr Res 2013 0.77
60 Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of D-amphetamine. Brain Res 2008 0.77
61 Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder. J Clin Psychiatry 2016 0.77
62 Decreased serum neurotrophin 3 in chronically medicated schizophrenic males. Neurosci Lett 2008 0.76
63 An open trial of adjunctive escitalopram in bipolar depression. J Clin Psychiatry 2006 0.76
64 Bipolar disorder affects behavior and social skills on the Internet. PLoS One 2013 0.76
65 [Anxiety disorders comorbidity in bipolar disorder]. Rev Bras Psiquiatr 2004 0.76
66 Improvement of behavioural and manic-like symptoms secondary to herpes simplex virus encephalitis with mood stabilizers: a case report. Int J Neuropsychopharmacol 2011 0.75
67 N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs? Rev Bras Psiquiatr 2011 0.75
68 Developmental staging models in bipolar disorder. Int J Bipolar Disord 2015 0.75
69 Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Can J Psychiatry 2014 0.75
70 Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain. J Neural Transm (Vienna) 2010 0.75
71 [Prevalence of mental disorders at a referral center for the Family Health Program in Santa Cruz do Sul, Rio Grande do Sul State, Brazil]. Cad Saude Publica 2008 0.75
72 A Study of Biological Rhythm Disturbances in Polish Remitted Bipolar Patients using the BRIAN, CSM, and SWPAQ Scales. Neuropsychobiology 2017 0.75
73 [Mental disorder, demographic variables and life satisfaction]. Rev Saude Publica 2008 0.75
74 The quest for better diagnosis: DSM-5 or RDoC? Rev Bras Psiquiatr 2013 0.75
75 [Mental disorders in a community assisted by the Family Health Program]. Cad Saude Publica 2008 0.75